GM-CSF-dependent CD301b<sup>+</sup> mouse lung dendritic cells confer tolerance to inhaled allergens.

Wilkinson, Christina L; Nakano, Keiko; Grimm, Sara A; Whitehead, Gregory S; Arao, Yukitomo; Blackshear, Perry J; Karmaus, Peer W; Fessler, Michael B et al. · Nat Commun · 2025

basic_science · Level V

Where this comes from

Abstract

The severity of allergic asthma is driven by the balance between allergen-specific T regulatory (Treg) and T helper (Th)2 cells. However, it is unclear whether specific subsets of conventional dendritic cells (cDCs) promote the differentiation of Tregs. We have identified a subset of lung resident type 2 cDCs (cDC2s) that display high levels of CD301b and have potent Treg-inducing activity ex vivo. Single-cell RNA sequencing and adoptive transfer experiments show that during allergic sensitization, many CD301b<sup>+</sup> cDC2s transition in a stepwise manner to CD200<sup>+</sup> cDC2s that selectively promote Th2 differentiation. GM-CSF augments the development and maintenance of CD301b<sup>+</sup> cDC2s in vivo, and also selectively expands Treg-inducing CD301b<sup>+</sup> cDC2s derived from bone marrow. Upon their adoptive transfer to recipient mice, lung-derived CD301b<sup>+</sup> cDC2s confer immunological tolerance to inhaled allergens. Thus, GM-CSF maintains lung homeostasis by increasing numbers of Treg-inducing CD301b<sup>+</sup> cDC2s.

Medical subject headings